tiprankstipranks
XTL Biopharmaceuticals Ltd. (IL:XTLB)
:XTLB
Israel Market

Xtl Bio (XTLB) Financial Statements

Compare
0 Followers

Xtl Bio Financial Overview

Xtl Bio's market cap is currently 68.99M. The company's EPS TTM is -0.005; its P/E ratio is ―; Xtl Bio is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -765.00K$ -880.00K$ -1.03M$ -948.00K$ -842.00K
EBITDA$ -764.00K$ -879.00K$ -1.03M$ -947.00K$ 0.00
Net Income$ -1.78K$ -1.35M$ 435.00K$ -782.00K$ -1.35M
Balance Sheet
Cash & Short-Term Investments$ 2.01M$ 3.72M$ 6.13M$ 6.04M$ 6.73M
Total Assets$ 2.43M$ 4.19M$ 6.62M$ 6.50M$ 7.21M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.40M$ -2.09M$ -2.97M$ -3.63M$ -4.46M
Total Liabilities$ 206.00K$ 187.00K$ 1.28M$ 254.00K$ 232.00K
Stockholders' Equity$ 2.22M$ 4.00M$ 5.33M$ 6.25M$ 6.98M
Cash Flow
Free Cash Flow$ -707.00K$ -901.00K$ -1.05M$ -851.00K$ -910.00K
Operating Cash Flow$ -707.00K$ -901.00K$ -1.05M$ -850.00K$ -908.00K
Investing Cash Flow$ 41.00K$ 36.00K$ 8.00K$ 32.00K$ 2.11M
Financing Cash Flow$ 0.00$ 0.00$ 385.00K$ 0.00$ 0.00
Currency in USD

Xtl Bio Earnings and Revenue History

Xtl Bio Debt to Assets

Xtl Bio Cash Flow

Xtl Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis